Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-22

Clinical Trial Update: Ketamine Effects as Preemptive Analgesia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating ketamine as preemptive analgesia for postoperative pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Pain, Postoperative | Phase 2, Phase 3 | Status: COMPLETED